Furthermore, diabetic NOS3−/− mice had a significant reduction in ejection fraction (EF) and fractional shrinking (FS) (Figure 7c–e) compared with non‐diabetic controls at 22 weeks of diabetes, an effect significantly restored using homoarginine treatment. Here, NOS3 is linked to diabetes mellitus.